These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102 [TBL] [Abstract][Full Text] [Related]
23. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975 [TBL] [Abstract][Full Text] [Related]
24. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease. Ooi CY; Bohane TD; Lee D; Naidoo D; Day AS Aliment Pharmacol Ther; 2007 Apr; 25(8):941-7. PubMed ID: 17402998 [TBL] [Abstract][Full Text] [Related]
25. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine. Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828 [TBL] [Abstract][Full Text] [Related]
26. Clinical predictors of thiopurine-related adverse events in Crohn's disease. Moran GW; Dubeau MF; Kaplan GG; Yang H; Eksteen B; Ghosh S; Panaccione R World J Gastroenterol; 2015 Jul; 21(25):7795-804. PubMed ID: 26167079 [TBL] [Abstract][Full Text] [Related]
27. Clinical and histologic features of Azathioprine-induced hepatotoxicity. Siramolpiwat S; Sakonlaya D Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864 [TBL] [Abstract][Full Text] [Related]
28. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Gisbert JP; González-Lama Y; Maté J Am J Gastroenterol; 2007 Jul; 102(7):1518-27. PubMed ID: 17391318 [TBL] [Abstract][Full Text] [Related]
29. Toxicity profile of thiopurines in inflammatory bowel disease: a retrospective cohort analysis. Labidi A; Hafi M; Ben Mustapha N; Serghini M; Fekih M; Boubaker J Tunis Med; 2020 May; 98(5):404-412. PubMed ID: 32548844 [TBL] [Abstract][Full Text] [Related]
30. Hepatotoxicity of 6-mercaptopurine in Crohn's disease. Gross R; Scapa E Am J Gastroenterol; 1992 Dec; 87(12):1885-6. PubMed ID: 1449165 [No Abstract] [Full Text] [Related]
31. [Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease]. Laish I; Pomeranz I; Kitay-Cohen Y; Konikof F Harefuah; 2012 Dec; 151(12):692-5, 720. PubMed ID: 23330262 [TBL] [Abstract][Full Text] [Related]
32. Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients. van Moorsel SAW; Deben DS; Creemers RH; Winkens B; Bus P; Pierik MJ; Simsek M; de Boer NKH; van Bodegraven AA; Wong DR Ther Drug Monit; 2022 Dec; 44(6):747-754. PubMed ID: 36070763 [TBL] [Abstract][Full Text] [Related]
33. Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease? Ledder OD; Lemberg DA; Ooi CY; Day AS J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):583-6. PubMed ID: 23783022 [TBL] [Abstract][Full Text] [Related]
34. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease]. Cohen-Ezra O; Avni Y; Morgenstern S; Ben-Ari Z Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258 [TBL] [Abstract][Full Text] [Related]
35. Factors for hepatitis B vaccination and abnormal liver function in Chinese patients with inflammatory bowel disease: a single center experience. Leung WK; Liu KSh; Seto WK; Chan KH; Tong T; Yuen MF; Lai CL; Hung IF J Dig Dis; 2013 Nov; 14(11):596-603. PubMed ID: 23870196 [TBL] [Abstract][Full Text] [Related]
36. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. Hutson JR; Matlow JN; Moretti ME; Koren G J Obstet Gynaecol; 2013 Jan; 33(1):1-8. PubMed ID: 23259868 [TBL] [Abstract][Full Text] [Related]
37. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity]. Corominas H; Díaz C; Vázquez G; Baiget M Rev Esp Enferm Dig; 2002 Oct; 94(10):635-6. PubMed ID: 12647415 [No Abstract] [Full Text] [Related]
38. Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment. Kreijne JE; de Veer RC; de Boer NK; Dijkstra G; West R; Moorsel SAW; de Jong DJ; van der Woude CJ; de Vries AC; Aliment Pharmacol Ther; 2019 Aug; 50(4):407-415. PubMed ID: 31359480 [TBL] [Abstract][Full Text] [Related]
39. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SH Aliment Pharmacol Ther; 2009 Mar; 29(6):654-61. PubMed ID: 19183142 [TBL] [Abstract][Full Text] [Related]
40. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study. Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]